In “the first in a series of conversations with officials at the Centers for Disease Control and Prevention (CDC) discussing the CDC’s role in global HIV and tuberculosis (TB) research and development,” the Center for Global Health Policy’s “Science Speaks” blog interviews Kayla Laserson, director of the Kenya Medical Research Institute (KEMRI)/CDC Field Research Station in Kisumu, Kenya. Laserson answers questions about her work with the CDC, the latest research projects underway at KEMRI/CDC, and progress in Kenya’s HIV response since she began working in Kisumu six years ago, among other topics (Mazzotta, 2/14).
Nature reports how “[i]n the hunt for drugs that target diseases in the developing world, … [p]harmaceutical companies are making entire libraries of chemical compounds publicly available, allowing researchers to rifle through them for promising drug candidates.” The journal writes, “The latest push for open innovation, unveiled last month as part of a World Health Organization road map to control neglected tropical diseases, will see 11 companies sharing their intellectual property to give researchers around the world a head start on investigating drug leads.”
Indian Authorities Vaccinate Children Crossing India-Pakistan Border; Distrust Of Polio Vaccines Grows In Pakistan
After going a year without recording a polio case, Indian health officials have begun vaccinating young children who cross the border to or from Pakistan at the Munabao railway station in Rajasthan state, BBC News reports. “The drive was launched after more than 175 cases of polio were reported in Pakistan, officials said,” the news agency writes (2/16).
The PBS NewsHour examines polio eradication efforts in India, which has gone an entire year without reporting a polio case. “For India, the challenge is to remain vigilant and polio free for two more years to officially fall off the list of endemic countries,” according to the news service (De Sam Lazaro, 2/20). “The success in India has been achieved through a partnership between the Indian government, with support from the World Health Organization (WHO), Rotary, UNICEF and with major contributions from the Bill & Melinda Gates Foundation,” BBC News reports in an analysis of India’s success. “The global effort to eradicate polio is the biggest public health initiative in history. It has cost billions and has already stopped a huge amount of disability and many deaths,” but the disease remains endemic in three countries — Afghanistan, Nigeria and Pakistan, the news service notes (Walsh, 2/19).
Pakistan and Afghanistan, “the world’s two worst polio-affected countries,” have “decided to form a joint block under the World Health Organization to eradicate the infectious disease — which causes motor paralysis and the atrophy of skeletal muscles, often resulting in permanent physical disability or deformity — by December 2012,” Inter Press Service reports. “The decision was made last year by the Technical Advisory Board (TAG), which is responsible for developing new strategies to wipe out the disease globally,” the news service notes.
“Poor-quality emergency immunization campaigns and low routine polio immunization coverage are helping the polio virus to spread in Chad, with 132 cases reported in 2011 — five times the number in 2010,” IRIN reports. “More commitment is needed across the board, especially from local health authorities, to try to get immunizations right, say aid agencies,” the news service adds.
U.N. Secretary-General Ban Ki-moon on Monday “launched a national polio vaccination campaign in Angola, where the crippling disease has returned despite being eradicated in 2001, and praised the government for its leadership on the issue,” the U.N. News Centre reports. “Angola provides a large majority of the funding needed to vaccinate the countryâ€™s children,” the news service writes. Ban said the return of polio to Angola within four years after it was eradicated in 2001 illustrated the importance of immunization against polio and other vaccine-preventable diseases, as well as responding to any new polio cases, according to the news service (2/27).
“Four in five children (83 percent) worldwide received the recommended three doses of diphtheria-tetanus-pertussis (DTP) vaccine during infancy in 2011, according to new data released in the Morbidity and Mortality Weekly Report and in the WHO Weekly Epidemiological Record (WER),” a WHO media note reports. According to the media note, “While substantial progress has been made, the new data show more than 22 million children, mostly living in less-developed countries, missed out on the three basic vaccinations during their first year of life in 2011” (11/1).
KPLU 88.5’s “Humanosphere” blog reports on a meeting of the HIV Vaccine Trials Network (HVTN), “the world’s largest HIV vaccine research network,” held in Seattle this week. “We actually don’t know what the agenda is,” HVTN Executive Director Jim Kublin said during a lecture, titled “Scientific Agenda, the Next Seven Years,” according to the blog. “But what makes it easier to laugh about not knowing where you’re going, he added, is that researchers today have a lot more tantalizing clues — beginning with the ground-breaking Thai vaccine trial known to this bunch as RV144,” the blog writes and describes the study (Paulson, 10/31).
“For the first time, with support from the GAVI Alliance, a pentavalent vaccine was introduced [in Myanmar this week] that will defend children against five potentially fatal diseases,” Dagfinn Hoybraten, vice president of the Norwegian Parliament and chair of the GAVI Alliance Board, writes in the Huffington Post’s “Impact” blog, adding, “Over the next six months, more than half a million children in [the country] will be protected from diphtheria, pertussis, tetanus, hepatitis B (hepB), and Haemophilus influenzae type b (Hib).” He continues, “Along with the pentavalent vaccine, Myanmar also rolled out the measles second dose vaccine as part of the routine immunization schedule,” and “[t]he country plans to reach 1.1 million children over the next year, giving them protection against a virus that kills hundreds of people a day.”